Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Nov;3(6):606-11.
doi: 10.3978/j.issn.2225-319X.2014.08.03.

Evolving strategies in the treatment of acute myocardial infarction-induced cardiogenic shock

Vakhtang Tchantchaleishvili  1 , Heidi Schubmehl  1 , Michael F Swartz  1 , William Hallinan  1 , H Todd Massey  1
Affiliations

Evolving strategies in the treatment of acute myocardial infarction-induced cardiogenic shock

Vakhtang Tchantchaleishvili et al. Ann Cardiothorac Surg. 2014 Nov.

Abstract

Despite advances in medical technology and re-vascularization interventions, the mortality rate for cardiogenic shock (CS) following acute myocardial infarction has remained at 50%. The majority of these mortalities are from left ventricular failure resulting in multi-system organ dysfunction. The field of mechanical circulatory support (MCS) has evolved within the past decade, with improved outcomes from extracorporeal membrane oxygenation as well as continuous-flow left ventricular assist devices (CF LVADs). In this paper, we discuss our institutional treatment strategies, the rationale for the protocol development, and our improved outcomes when using MCS in patients with refractory CS following acute myocardial infarction.

Keywords: Cardiogenic shock (CS); acute myocardial infarction; mechanical circulatory support (MCS); ventricular assist device (VAD).

PubMed Disclaimer

Figures

Figure 1
Figure 1
Treatment strategy for patients with acute myocardial infarction cardiogenic shock (AMICS). VAD, ventricular assist device; CPR, cardiopulmonary resuscitation; CF VAD, continuous flow ventricular assist device; ECMO, extracorporeal membrane oxygenation.
See this image and copyright information in PMC

References

    1. Reynolds HR, Hochman JS. Cardiogenic shock: current concepts and improving outcomes. Circulation 2008;117:686-97. - PubMed
    1. Hochman JS, Buller CE, Sleeper LA, et al. Cardiogenic shock complicating acute myocardial infarction--etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol 2000;36:1063-70. - PubMed
    1. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med 1999;341:625-34. - PubMed
    1. Hochman JS, Sleeper LA, White HD, et al. One-year survival following early revascularization for cardiogenic shock. JAMA 2001;285:190-2. - PubMed
    1. Brodie BR, Stuckey TD, Muncy DB, et al. Importance of time-to-reperfusion in patients with acute myocardial infarction with and without cardiogenic shock treated with primary percutaneous coronary intervention. Am Heart J 2003;145:708-15. - PubMed